PSA testing: When it's useful, when it's not

MOspace/Manakin Repository

Breadcrumbs Navigation

PSA testing: When it's useful, when it's not

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/10961

[+] show full item record


Title: PSA testing: When it's useful, when it's not
Author: Slatkoff, Susan; Gamboa, Stephen; Zolotor, Adam J.; Mounsey, Anne L.; Jones, Kohar
Keywords: cancer screening
diagnostic testing
Date: 2011-06
Publisher: Family Physicians Inquiries Network
Citation: Journal of Family Practice, 50(6) 2011: 357-360.
Abstract: Do not routinely screen all men over the age of 50 for prostate cancer with the prostate-specific antigen (PSA) test. Consider screening men younger than 75 with no cardiovascular or cancer risk factors—the only patient population for whom PSA testing appears to provide even a small benefit. Strength of recommendation B: Based on a meta-analysis of 6 randomized controlled trials (RCTs) with methodological limitations, and a post hoc analysis of a large RCT.
URI: http://hdl.handle.net/10355/10961

This item appears in the following Collection(s)

[+] show full item record